GlassScriptPhysician profile
Katherine M Swing
NPI 1902866106
$2,319.96
in general payments reported to CMS, 2019-2025
28 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $105 · 2021: $445 · 2022: $630 · 2023: $238 · 2024: $110 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.10 |
| Education | $113.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $513.58 | 2019-2022 | |
| Aspira Women'S Health INC | $253.09 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $178.82 | 2019-2025 | Veozah, Myrbetriq |
| Ethicon US, LLC | $143.92 | 2022 | |
| Millicent US INC | $132.23 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $119.42 | 2019-2024 | |
| Amgen INC. | $113.91 | 2019-2023 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $103.34 | 2019 | |
| Organon LLC | $77.82 | 2021-2023 | Nexplanon |
| Novo Nordisk INC | $75.80 | 2024-2025 | Wegovy |
| Mylan Pharmaceuticals INC. | $69.17 | 2021-2022 | |
| Lilly USA, LLC | $67.97 | 2024-2025 | Zepbound, Mounjaro |
| Therapeuticsmd, INC. | $52.12 | 2019-2022 | |
| Avion Pharmaceuticals | $51.97 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $49.42 | 2022-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $45.35 | 2019-2022 | |
| Coopersurgical, INC. | $38.22 | 2019-2022 | |
| Exeltis, USA INC. | $34.49 | 2021-2022 | |
| Becton, Dickinson and Company | $33.60 | 2022 | |
| Myovant Sciences INC. | $33.05 | 2021 | |
| Exact Sciences Corporation | $28.89 | 2025 | The Cologuard Plus Collection Kit |
| Lupin INC. | $26.33 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $15.09 | 2019 | |
| Evofem Biosciences, INC. | $15.06 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.40 | 2022 | |
| Merck Sharp & Dohme LLC | $12.02 | 2022 | |
| Minerva Surgical, INC | $11.80 | 2019 | |
| Roche Diagnostics Corporation | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Swing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.